The path to routine use of genomic biomarkers in the cancer clinic
about
Variation-preserving normalization unveils blind spots in gene expression profiling.Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsDocking of CDK1 with antibiotic drugs revealed novel therapeutic value in breast ductal cancer in situ.Experimental design and quantitative analysis of microbial community multiomics.Prediction of early breast cancer patient survival using ensembles of hypoxia signatures
P2860
The path to routine use of genomic biomarkers in the cancer clinic
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The path to routine use of genomic biomarkers in the cancer clinic
@ast
The path to routine use of genomic biomarkers in the cancer clinic
@en
The path to routine use of genomic biomarkers in the cancer clinic
@nl
type
label
The path to routine use of genomic biomarkers in the cancer clinic
@ast
The path to routine use of genomic biomarkers in the cancer clinic
@en
The path to routine use of genomic biomarkers in the cancer clinic
@nl
prefLabel
The path to routine use of genomic biomarkers in the cancer clinic
@ast
The path to routine use of genomic biomarkers in the cancer clinic
@en
The path to routine use of genomic biomarkers in the cancer clinic
@nl
P2860
P356
P1433
P1476
The path to routine use of genomic biomarkers in the cancer clinic
@en
P2860
P304
P356
10.1101/GR.191114.115
P407
P577
2015-10-01T00:00:00Z